EGFR and non-small cell lung carcinoma: It acts on several key targets—epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), and rearranged during transfection (RET) tyrosine kinase—and is used clinically in oncology, including non-small-cell lung carcinoma [6,7].